Drug Research

One of the most important trade fairs in the pharmaceutical industry will soon be taking place in Japan as it sees a huge resurgence in global trade with companies from the west, especially Switzerland, the USA, and the UK,...

Uppsala University researchers have created an artificial blood-brain barrier model that can be used to assess the efficacy of anti-body-based medicines while reducing animal experimentation. The treatment of protein clumps that happen to be prevalent in neurodegenerative illnesses is made...

Scientists from the University of Portsmouth have settled on a novel genetic link between Duchenne muscular dystrophy and cancer. Duchenne muscular dystrophy, which happens to be a muscle-wasting disease, is known to be caused by mutations when it comes...

The Hong Kong government announced plans to add $500 million to the Chinese Medicine Development Fund beginning with this fiscal year during a budget speech in order to support the commissioning of large-scale training, research, and publicity projects on...

Bend Bioscience announced the opening of an R&D and Innovation lab in Bend, Oregon. The 4,500 square-foot facility includes lab and office space as well as a work environment for almost 20 employees. The facility is part of a larger...

Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group (Chiesi Group), announced that the U.S. FDA has approved Lamzede® (velmanase alfa-tycv) for the treatment of non-central nervous system manifestations of alpha-mannosidosis (AM)...

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines and Life Edit Therapeutics Inc., an ElevateBio company focused on next-generation gene editing technologies and therapeutics, announced a strategic research and development collaboration to discover and develop...